Synapsoft logo
AI Insights from Disclosures
Searching...
GENINUS Inc. 389030
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
GENINUS Inc. is a bio-venture company spun off from the Samsung Genome Institute at Samsung Medical Center on April 20, 2018, whose main business is research and development of genome analysis technology based on NGS (Next Generation Sequencing) and the development and manufacture of genome analysis solutions.
Representative Director Park Ungyang
Founded April 20, 2018
Corporation Type KOSDAQ
Industry Classification Research and experimental development on medical sciences and pharmacy
Corporate number 11011-6728781
Business number 203-88-01251
Phone Number 02-6949-6570
Fax Number 02-6949-6580
Website kr-geninus.com
Company Address 70 Jeongui-ro, Songpa-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant